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Abstract: Repeated cocaine alters glutamate neurotransmission, in part, by
reducing cystine-glutamate exchange via system xc-, which maintains
glutamate levels and receptor stimulation in the extrasynaptic compartment.
In the present study, we undertook two approaches to determine the
significance of plasticity involving system xc-. First, we examined whether the
cysteine prodrug N-acetylcysteine attenuates cocaine-primed reinstatement
by targeting system xc-. Rats were trained to self-administer cocaine (1
mg/kg/200 µl, IV) under extended access conditions (6 hr/day). After
extinction training, cocaine (10 mg/kg, IP) primed reinstatement was
assessed in rats pretreated with N-acetylcysteine (0–60 mg/kg, IP) in the
presence or absence of the system xc- inhibitor (S)-4-carboxyphenylglycine
(CPG; 0.5 µM; infused into the nucleus accumbens). N-acetylcysteine
attenuated cocaine-primed reinstatement, and this effect was reversed by coadministration of CPG. Secondly, we examined whether reduced system x cactivity is necessary for cocaine-primed reinstatement. To do this, we
administered N-acetylcysteine (0 or 90 mg/kg, IP) prior to twelve daily selfadministration sessions (1 mg/kg/200 µl, IV; 6 hr/day) since this procedure
has previously been shown to prevent reduced activity of system x c-. On the
reinstatement test day, we then acutely impaired system xc- in some of the
rats by infusing CPG (0.5 µM) into the nucleus accumbens. Rats that had
received N-acetylcysteine prior to daily self-administration sessions exhibited
diminished cocaine-primed reinstatement; this effect was reversed by infusing
the cystine-glutamate exchange inhibitor CPG into the nucleus accumbens.
Collectively these data establish system xc- in the nucleus accumbens as a
key mechanism contributing to cocaine-primed reinstatement.
Keywords: extrasynaptic, nonvesicular, glutamate, microdialysis, cystineglutamate antiporter, reinstatement

Long-term plasticity resulting in altered excitatory
neurotransmission within corticostriatal pathways has been implicated
in addiction. Human cocaine abusers exposed to craving-inducing
stimuli exhibit increased activation of excitatory circuits originating in
cortical regions, including orbital or prefrontal cortex, and projecting to
the ventral striatum (Breiter et al., 1997; Dackis and O'Brien, 2005;
Volkow et al., 2005). Preclinical data indicate that an injection of
cocaine increases Fos protein expression throughout the corticostriatal
pathway in rats engaged in cocaine seeking (Neisewander et al., 2000)
and that transient inactivation of the prefrontal cortex or nucleus
accumbens core blocks cocaine-primed reinstatement in rats
(McFarland and Kalivas, 2001). Inhibition of excitatory
neurotransmission in the nucleus accumbens by preventing activation
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of corticostriatal pathways, stimulating group II metabotropic
glutamate autoreceptors, or blocking AMPA receptors also blocks
cocaine-primed reinstatement in rats (Cornish and Kalivas, 2000; Park
et al., 2002; Baker et al., 2003; McFarland et al., 2003; Schmidt et
al., 2005; Peters and Kalivas, 2006). These data indicate that
regulation of synaptic glutamate represents a novel approach in the
treatment of cocaine addiction (Volkow and Fowler, 2000; Dackis,
2004).
System xc- may be a key mechanism underlying cocaineinduced changes in glutamate signaling within corticostriatal pathways
that contribute to pathological cocaine seeking. First, cystineglutamate exchange via system xc- supplies nonvesicular glutamate in
the extrasynaptic compartment that stimulates extrasynaptic group II
metabotropic glutamate receptors (mGluR) in the nucleus accumbens
and prefrontal cortex (Baker et al., 2002; Xi et al., 2002a; Moran et
al., 2005). This is important because stimulation of group II mGluRs
inhibits synaptic release of glutamate (Baskys and Malenka, 1991;
Cochilla and Alford, 1998; Schoepp, 2001; Moran et al., 2005).
Repeated cocaine blunts cystine-glutamate exchange (Baker et al.,
2003; Madayag et al., 2007) which results in reduced basal glutamate
levels in the nucleus accumbens (Pierce et al., 1996; Reid and Berger,
1996; Baker et al., 2003), and reduced autoregulation of synaptic
glutamate by group II mGluRs (Xi et al., 2002b). Likely as a result, a
cocaine challenge increases synaptic release of glutamate in cocainewithdrawn rats (Pierce et al., 1996; Reid and Berger, 1996; Baker et
al., 2003) that occurs as a result of activation of corticostriatal
pathways (McFarland et al., 2003).
Preclinical studies have shown N-acetylcysteine to be effective in
blocking compulsive drug-seeking in rodents (Baker et al., 2003;
Madayag et al., 2007; Zhou and Kalivas, 2007) and data from openlabel trials have shown reduced cocaine use and craving in human
cocaine abusers (Larowe et al., 2006; Mardikian et al., 2007).
Although the effects of N-acetylcysteine were attributed to increased
cystine-glutamate exchange by system xc-, data indicate that Nacetylcysteine may alter glutamate signaling through cellular
mechanisms distinct from system xc-. Specifically, N-acetylcysteine or
cysteine resulting from deacetylation of N-acetylcysteine has been
shown to influence the activity of sodium-dependent glutamate
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transporters and glutamate receptors including NMDA and AMPA
receptors (Janaky et al., 2000; Aoyama et al., 2006; Chase et al.,
2007). As a result, the mechanism underlying the effects of Nacetylcysteine needs to be identified.
The present study examines the therapeutic potential of
targeting system xc- to reduce drug-seeking behavior. First, we
examined whether the cysteine prodrug N-acetylcysteine attenuates
cocaine-primed reinstatement by targeting system xc-. To do this, we
examined the capacity of N-acetylcysteine to block cocaine-primed
reinstatement in the presence or absence of the system xc- inhibitor
(S)-4-carboxyphenylglycine (Ye et al., 1999; Patel et al., 2004) (CPG;
0.5 µM; infused into the nucleus accumbens). N-acetylcysteine
attenuated cocaine-primed reinstatement and this effect was reversed
by co-administration of CPG. Secondly, we examined whether reduced
system xc- activity is necessary for cocaine-primed reinstatement. To
do this, we administered N-acetylcysteine (0 or 90 mg/kg, IP) prior to
twelve daily self-administration sessions (1 mg/kg, IV; 6 hr/day). This
procedure has previously been shown to prevent reduced activity of
system xc- and cocaine-primed reinstatement (Madayag et al., 2007).

Experimental Procedures
Subjects
These experiments utilized male Sprague Dawley rats (Harlan,
Indianapolis, IN) weighing 275–325 grams upon arrival. Rats were
individually housed in a temperature-controlled colony room with a 12h reversed light/dark cycle. Housing conditions and experimental
protocols were approved by the Marquette University Institutional
Animal Care and Use Committee and carried out according to the NIH
Guide for the Care and Use of Laboratory Animals (revised 1996).

Surgeries
Rats included in self-administration studies were implanted with
indwelling catheters under ketamine HCl (100 mg/kg, IP, Fort Dodge
Animal Health, Fort Dodge, IA) and xylazine (2 mg/kg, IP, Lloyd
Laboratories, Shenandoah, IA, USA) anesthesia. A silicon tubing
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catheter (Dow Corning Co., Midland, MI; 0.64 mm ID; 1.19 mm OD)
was implanted such that it entered the jugular vein through the right
posterior facial vein and terminated at the right atrium. The catheter
was sutured to the vein at the entry point. The distal aspect of the
catheter, which consisted of a 22-gauge guide cannula (Plastics One
Inc., Roanoke, VA) attached with dental acrylic to a piece of
polypropylene monofilament surgical mesh (Atrium Medical, Co.,
Hudson, NH), exited 2 cm posterior to the scapulae. Throughout the
experiment, catheters were filled daily with a heparin solution (83
i.u./ml; Elkins-Sinn, Inc., Cherry Hill, NJ) and capped when
disconnected from the leash/delivery line assembly.
Rats included in microdialysis studies were also implanted with
indwelling bilateral guide cannulae (20 gauge, 14 mm; Plastics One,
Roanoke VA) using the following coordinates derived from Paxinos and
Watson (1986): + 0.9 mm anterior, ± 2.5 mm mediolateral to
Bregma, and −4.4 mm from the surface of the skull at a 6° angle from
vertical. The placement of the active region of the microdialysis probe,
which began 2 mm beyond the ventral tip of the guide cannulae, was
primarily in the nucleus accumbens core. Following surgery, rats were
given at least five days to recover prior to testing. During this time,
rats were provided acetaminophen (480 mg/L) in their drinking water
and injected daily with a sterile cefazolin antibiotic solution (15 mg,
IV; West-Ward Pharmaceutical Co., Eatontown, NJ).

Cocaine Self-Administration Training
Self-administration occurred in operant chambers (ENV-008CT,
MED-Associates Inc., St Albans, VT, USA) housed in sound attenuating
cubicles (ENV-016M, MED-Associates Inc.) and equipped with two
retractable levers, two stimulus lights, and a water bottle. At least five
days after surgery, rats were food restricted for 18 hr with water
available ad libitum. Rats were then placed into the operant chambers
overnight and responses on the lever designated as active resulted in
the delivery of food pellets under a fixed ratio 1 schedule of
reinforcement. Daily food training continued until subjects received at
least 150 food rewards in a session, which typically occurred following
the first session. Rats then underwent drug self-administration training
during daily 2-hr sessions in which operant responses on the active
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lever were reinforced with an infusion of cocaine (0.5 mg/kg/200 µl IV,
National Institute on Drug Abuse, Bethesda, MD, USA) under a fixed
ratio 1 schedule of reinforcement. Each reinforced lever response
resulted in the illumination of the stimulus light located above the
active lever and was followed by a 25-s time-out period. Responding
on a second, inactive lever located on the back wall was recorded but
had no programmed consequences. Acquisition of cocaine selfadministration was operationally defined as < 10% variation in daily
responding over at least three consecutive sessions. Once rats met the
acquisition criteria, they were advanced to maintenance sessions in
which saline or cocaine was self-administered under extended-access
conditions (1.0 mg/kg/200 µl IV; 6-hr/day for 12 days).

Extinction training
After completing twelve maintenance self-administration
sessions, rats remained in their home cages for seven days prior to
extinction training. A seven day delay was used to ensure an adequate
abstinent period prior to reinstatement, even in rats that quickly
extinguished responding. Extinction training involved placing rats into
the operant chambers for 2-hr/day as described above in the selfadministration section except each active lever press now resulted in
an infusion of saline. This continued until the mean number of lever
presses was ≤ 10 responses across at least three sessions, at which
point rats were tested for drug-primed reinstatement. Because the
average number of extinction sessions needed to meet criteria (±
SEM) was 15.4 ± 4.3, reinstatement testing occurred on average 22
days after the last self-administration session.

Histology
Rats included in the microdialysis studies were given an
overdose of pentobarbital (60 mg/kg, IP), and the brains fixed by
intracardiac infusion of 0.9% saline followed by 2.5% formalin
solution. Brains were then removed and stored in 2.5 % formalin for at
least seven days prior to sectioning. The tissue was then blocked and
coronal sections (100 µM) were cut and stained with cresyl violet to
verify probe placements.
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Statistical analyses
The SPSS statistics package (version 16) was used to perform
the statistical analyses. Data was analyzed using analysis of variance
(ANOVA) with drug treatment (e.g., dose of N-acetylcysteine, cocaine
history) as between subject factors and self-administration session or
phase of experiment (extinction, reinstatement) as repeated factors.
Tukeys HSD test were used to analyze significant (p ≤ .05)
interactions or main effects. Student t-tests were used in instances
where main effects or simple main effects involving only two groups
were further analyzed as a result of a significant interaction.

Experiment 1
N-acetylcysteine has been shown to block cocaine-primed
reinstatement in rats that had self-administered under short access
conditions (Baker et al., 2003). In the present study, we examined
whether N-acetylcysteine targets cystine-glutamate exchange by
system xc-to produce this effect. Rats were trained to self-administer
cocaine as described above under extended access conditions.
Following extinction training, rats were tested for cocaine-primed
reinstatement. On the night before the reinstatement test,
microdialysis probes, constructed as previously described (Baker et al.,
2003), were inserted into indwelling guide cannula. Rats were then
housed overnight in the self-administration chambers. The next day,
dialysis buffer (5 mM glucose, 140 mM NaCl, 1.4 mM CaCl2, 1.2 mM
MgCl2, and 0.15% phosphate buffer saline, pH 7.4) was pumped
through the probes at a rate of 1 µl/min for at least 3 hr. After this,
vehicle or N-acetylcysteine (30–60 mg/kg, IP) was administered at the
same time that vehicle or (S)-4 carboxyphenylglycine (CPG; 0.5 µM)
was added to the dialysis buffer. Sixty minutes later, rats received a
systemic injection of cocaine (10 mg/kg, IP). The levers were then
extended into the chambers and responding was monitored for 120
min.

Experiment 2
Repeated cocaine produces a reduction in cystine-glutamate
exchange from system xc-. In the present study, we explored the
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contribution of diminished system xc- activity to cocaine-induced
reinstatement of drug seeking. Rats were trained to self-administer
cocaine as described above with the exception that rats received saline
or N-acetylcysteine (90 mg/kg, IP) injections thirty minutes prior to
each session of cocaine self-administration during both the acquisition
and maintenance phases. Note, administration of N-acetylcysteine
prior to daily cocaine self-administration has been shown to prevent
reduced cystine-glutamate exchange by system xc- (Madayag et al.,
2007). Once self-administration was complete, rats underwent a seven
day forced abstinence period, which was followed by extinction training
as described above. On the night before the reinstatement test,
microdialysis probes, constructed as previously described (Baker et al.,
2003), were inserted into indwelling guide cannula. Rats were then
housed overnight in the self-administration chambers. The next day,
dialysis buffer (5 mM glucose, 140 mM NaCl, 1.4 mM CaCl2, 1.2 mM
MgCl2, and 0.15% phosphate buffer saline, pH 7.4) was pumped
through the probes at a rate of 1 µl/min for at least 3 hr. After this,
vehicle or CPG (0.5 µM) was added to the dialysis buffer for the
duration of the experiment. Sixty minutes later, rats received a
systemic injection of cocaine (10 mg/kg, IP). The levers were then
extended into the chambers and responding was monitored for 120
min.

Results
N-acetylcysteine Blocks Cocaine-Primed Reinstatement
by Targeting System xcIn the present study, we tested the hypothesis that Nacetylcysteine blocks cocaine-induced reinstatement of drug seeking
by targeting system xc-. Figure 1 illustrates the impact of acute
administration of N-acetylcysteine in the presence or absence of the
cystine-glutamate exchange inhibitor CPG on cocaine-primed
reinstatement of drug seeking. A comparison of lever pressing on the
last day of extinction or the reinstatement test day produced an
interaction between day and drug treatment (ANOVA: F4,35=18.949,
p<.001). Post hoc analyses indicated that administration of the high
dose of N-acetylcysteine in the absence of cocaine failed to reinstate
cocaine seeking since there was no increase in lever pressing on the
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reinstatement test relative to behavior expressed on the last day of
extinction (Students paired T-test, p<.05). In contrast, a cocaine
prime reinstated cocaine seeking in all groups, although the magnitude
of reinstatement was significantly lower in rats treated with either dose
of N-acetylcysteine when administered in the absence of CPG infusions
into the nucleus accumbens (Tukey HSD, p<.05). Interestingly,
infusion of CPG into the nucleus accumbens reversed the effects of
acute N-acetylcysteine administration such that these rats exhibited
significantly more lever presses relative to rats pretreated with Nacetylcysteine in the absence of CPG (Tukey HSD, p<.05).

Figure 1

N-acetylcysteine blocks cocaine-primed reinstatement by targeting

system xc-. The data depict the mean (+ SEM) number of lever presses on the last
extinction session or on the reinstatement test day. Drug assignments indicate
treatment on only the reinstatement test day (N=6–12/group as indicated in the bar
graphs). N-acetylcysteine (0–60 mg/kg, IP) was injected at the time that (S)-4
carboxyphenylglycine (CPG; 0–0.5 µM) was added to the dialysis buffer; rats then
received a cocaine injection (10 mg/kg, IP) sixty min later. The operant levers were
then extended into the chamber and responding was monitored for 120 min. *
indicates a significant difference from extinction responding (t-test, p<.05); #
indicates a significant difference from rats treated with cocaine only (Tukey, p<.05); +
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indicates a significant increase relative to rats treated with cocaine + N-acetylcysteine
(60 mg/kg; Tukey, p<.05).

Decreased cystine-glutamate exchange contributes to
cocaine-primed reinstatement
The present study tested the hypothesis that reduced cystineglutamate exchange by system xc- is necessary for cocaine-primed
reinstatement. To do this, N-acetylcysteine was administered prior to
each daily session of cocaine self-administration, which has previously
been shown to prevent cocaine-induced plasticity involving system xc(Madayag et al., 2007). In figure 2, we present the impact of daily Nacetylcysteine on cocaine intake during twelve maintenance sessions
of cocaine self-administration under extended-access conditions. A
comparison of the number of cocaine infusions with drug treatment as
a between subjects variable and time or daily session as a repeated
measure failed to produce an interaction between the terms (ANOVA:
F11,264=0.683, p=.754), but produced a significant main effect of time
(ANOVA: F11,264=8.54, p<.001) and a strong trend toward a main
effect of drug treatment (ANOVA: F1,24=4.16, p=.053).

Figure 2

N-acetylcysteine reduces cocaine intake across daily sessions of cocaine

self-administration. Data depict the mean (± SEM) number of cocaine infusions (1.0
mg/kg/200 µl, IV) obtained during twelve daily maintenance self-administration
sessions (6-hr/day). Thirty min prior to each daily session, rats received either vehicle
(1 ml/kg; N=14) or N-acetylcysteine (90 mg/kg, IP; N=12).
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Figure 3 illustrates the impact of N-acetylcysteine administered
prior to daily sessions of cocaine self-administration on extinction
responding following a seven day forced abstinence period. A
comparison of the number of the number of lever presses with
pretreatment history as a between subjects variable and day of the
experiment as a repeated measure failed to produce an interaction
between the terms (ANOVA: F4,96=0.364, p=.833), but produced a
significant main effect of time (ANOVA: F4,96=11.95, p<.001) and
pretreatment history (ANOVA: F1,24=6.165, p=.02). Note, the above
analyses were conducted on just the first five extinction sessions since
some rats met the acquisition criteria within five sessions.

Figure 3

N-acetylcysteine pretreatment during self-administration training results

in lower levels of extinction responding. Following self-administration training, rats
remained in the home cage for 7 days, and then underwent extinction training in
which lever presses resulted in a saline infusion. Data depict the mean (± SEM)
number of lever presses during the first five extinction sessions (2 hr/day). The first
five sessions are depicted because some rats met the extinction criteria prior to the
sixth session. Drug assignments indicate treatment during self-administration training
(N=12–14/group). * indicates a main effect of drug treatment (ANOVA, p<.05).
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Figure 4 illustrates the impact of the cystine-glutamate
exchange inhibitor CPG infused into the nucleus accumbens on
cocaine-primed reinstatement by rats that had received Nacetylcysteine prior to daily sessions of cocaine self-administration. A
comparison of lever pressing on the last day of extinction or the
reinstatement test day produced an interaction between day and drug
treatment history (ANOVA: F2,22=5.45, p=.012). Analysis of the simple
main effect comparing response rates on the reinstatement test
session only yielded a significant effect of drug treatment history
(ANOVA: F2,22=5.40, p=.012). Post hoc analyses indicated that rats
that had received N-acetylcysteine prior to daily sessions of cocaine
self-administration, a procedure previously shown to prevent reduced
cystine-glutamate exchange (Madayag et al., 2007), exhibited blunted
cocaine-primed reinstatement (Tukey HSD, p<.05), even though
testing occurred at least 12 days after the last administration of Nacetylcysteine (figure 4). Further, acute disruption of cystineglutamate exchange following intra-accumbens infusion of CPG in rats
that had received N-acetylcysteine pretreatments during cocaine selfadministration training restored cocaine-primed reinstatement to levels
observed in controls that had no history of N-acetylcysteine
pretreatments (Tukey HSD, p<.05). Although the nucleus accumbens
was the region primarily infused with CPG, the microdialysis probe for
some subjects also extended into the striatum dorsal to the nucleus
accumbens or the olfactory tubercles (figure 5).
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Figure 4

Acute disruption of cystine-glutamate exchange reverses the impact of

daily N-acetylcysteine pretreatments on cocaine-primed reinstatement. Data depict
the mean number of lever presses (± SEM) on the last extinction session or the
reinstatement test day. Rats had a history of vehicle or N-acetylcysteine
pretreatments prior to each daily session of cocaine self-administration. On the
reinstatement test day, rats received intra-accumbens infusions of vehicle or CPG sixty
min prior to an injection of cocaine (10 mg/kg, IP). The operant levers were then
extended into the chamber and responding was monitored for 120 min.
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Figure 5

A schematic illustrating the placement of the 2 mm active membrane

portion of the microdialysis probe for the rats included in the microdialysis study. The
active regions of the microdialysis probes were primarily located in the nucleus
accumbens core, although aspects of nucleus accumbens shell, the striatum dorsal to
the nucleus accumbens, and the olfactory tubercles were likely sampled as well.

Discussion
Plasticity resulting in abnormal activation of corticostrial
pathways appears to contribute to craving in human drug abusers
(Breiter et al., 1997; Dackis and O'Brien, 2005; Volkow et al., 2005).
Previous reports have provided indirect evidence that reduced
nonvesicular glutamate release by system xc- may contribute to
cocaine-primed reinstatement (Madayag et al., 2007), and that it
represents a novel target in the treatment of cocaine addiction (Baker
et al., 2003; Larowe et al., 2006; Mardikian et al., 2007). In the
present report, we undertook two approaches to directly examine the
contribution of system xc- to cocaine-induced reinstatement. First, we
demonstrate that the cysteine prodrug N-acetylcysteine attenuates
cocaine-primed reinstatement by targeting system xc-. Second, we
found that reduced system xc- activity is necessary for robust cocaine-
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primed reinstatement. Collectively, these data establish system xc- in
the nucleus accumbens as a key mechanism contributing to cocaineprimed reinstatement and further establish it as a novel target for the
treatment of cocaine addiction.

N-acetylcysteine Blunts Cocaine-Induced Reinstatement
by Targeting System xcAcute administration of N-acetylcysteine blocks cocaine-induced
reinstatement (Baker et al., 2003), and this was thought to be due to
increased cystine-glutamate exchange. However, recent data indicate
that N-acetylcysteine may block reinstatement by targeting sites other
than cystine-glutamate exchange. Specifically, N-acetylcysteine or
cysteine resulting from deacetylation of N-acetylcysteine has been
shown to regulate the activity of sodium-dependent glutamate
transporters, NMDA receptors, and AMPA receptors (Janaky et al.,
2000; Aoyama et al., 2006; Chase et al., 2007). In the present study,
we replicate finding that acute administration of N-acetylcysteine
attenuates cocaine-primed reinstatement when administered prior to a
cocaine injection. Moreover, we found that this effect is blocked by
infusion of the cystine-glutamate exchange inhibitor CPG into the
nucleus accumbens. Because CPG also acts at metabotropic glutamate
receptors, we selected a concentration (500 nM) that is significantly
lower than the EC50s of CPG to block group I mGluRs (40–65 µM) or
stimulate group II mGluRs (570–970 µM) (Cavanni et al., 1994;
Thomsen et al., 1994; Sekiyama et al., 1996). As a result, the present
findings indicate that N-acetylcysteine blocks cocaine-induced
reinstatement of drug seeking by targeting cystine-glutamate
exchange by system xc- in the nucleus accumbens.
It is noteworthy that blockade of reinstatement by Nacetylcysteine in the present study occurred in rats trained to selfadminister cocaine under extended-access conditions, which has been
suggested to represent a more stringent test of the therapeutic
potential (Ahmed and Koob, 1998; Mantsch et al., 2004; Kippin et al.,
2006). Further, these data are consistent with the findings of recent
open-label trials demonstrating reduced cocaine craving and use in
human cocaine abusers receiving N-acetylcysteine (Larowe et al.,
2006; Mardikian et al., 2007). Although clinical trials are needed to
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more stringently determine the anticraving efficacy of Nacetylcysteine, these data establish, to at least some degree,
predictive validity for the reinstatement paradigm as a screen for novel
pharmacotherapies for addiction.
Administration of N-acetylcysteine prior to daily sessions of
cocaine self-administration under extended access conditions has
previously been shown to prevent escalation of drug intake (Madayag
et al., 2007). In the present report, we obtained a significant increase
in drug intake regardless of N-acetylcysteine pretreatment. Differences
between the two studies include dose of N-acetylcysteine, number of
self-administration sessions, and subjects per group. The latter may be
particularly important because the present study obtained a strong,
but nonsignificant trend towards N-acetylcysteine-induced blockade of
escalation (p=.053). Further, the magnitude of escalation observed in
the control subjects of the present study was larger than we previously
obtained. Collectively, additional data may be needed to determine the
role of cystine-glutamate exchange in the emergence of escalation of
drug intake.
It may seem counterintuitive that increased glutamate release
from system xc- reduces cocaine-induced behaviors in rodents and
drug-craving and use in humans that are thought to be dependent, at
least in part, on glutamate signaling (Cornish and Kalivas, 2000; Baker
et al., 2003; Di Ciano and Everitt, 2003; McFarland et al., 2003;
Larowe et al., 2006). However, this may reflect the existence of
multiple, functionally-distinct pools of glutamate. Cocaine increases
glutamate in the synaptic cleft following corticostriatal activation
thereby generating behaviors dependent upon postsynaptic receptor
stimulation (Cornish and Kalivas, 2000; McFarland et al., 2003; Di
Ciano and Everitt, 2004; Suto et al., 2004). System xc- releases
glutamate into the extrasynaptic compartment resulting in the
stimulation of group II mGluRs (Baker et al., 2002; Baker et al., 2003;
Moran et al., 2005). By stimulating extrasynaptic group II mGluRs
without exerting postsynaptic effects, extrasynaptic glutamate appears
to inhibit synaptic release (Baker et al., 2002; Moran et al., 2005).
Sodium-dependent glutamate transporters may partition the two pools
by limiting glutamate overflow from the synapse into the extrasynaptic
compartment (Danbolt, 2001), and restricting entry of nonvesicular
glutamate into the synapse (Jabaudon et al., 1999). To the extent that
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NR2B receptors are located outside the synapse, this hypothesis is
supported by the recent observation that glutamate release from
astrocytes appears to stimulate extrasynaptic, but not synaptic NMDA
receptors (D'Ascenzo et al., 2007).

Targeting system xc- to prevent plasticity involving
extracellular glutamate
Cocaine-induced seeking in rodents and use in humans arises,
at least in part, as a result of corticostriatal circuits that are rendered
overactive as a result of drug-induced plasticity (Breiter et al., 1997;
Volkow et al., 1999; Park et al., 2002; McFarland et al., 2003; Schmidt
et al., 2005; Volkow et al., 2005). Reduced cystine-glutamate
exchange may contribute to this process since it provides endogenous
tone to group II mGluRs that function to inhibit synaptic release
(Baskys and Malenka, 1991; Cochilla and Alford, 1998; Schoepp,
2001; Moran et al., 2005). Further, repeated cocaine produces a
persistent decrease in cystine-glutamate exchange by system xc- in
the nucleus accumbens (Baker et al., 2003; Madayag et al., 2007),
and these changes may be necessary for cocaine-induced behavioral
plasticity used to model aspects of addiction. In support, we have
previously shown that the cysteine prodrug N-acetylcysteine
administered prior to daily sessions of cocaine self-administration or
experimenter-delivered cocaine prevents plasticity involving system
xc-, escalation of drug intake, behavioral sensitization, and cocaineprimed reinstatement (Madayag et al., 2007). Further, in the present
study, rats pretreated with N-acetylcysteine prior to daily cocaine selfadministration show a strong trend toward blunted cocaine intake,
reduced extinction responding, and lower levels of cocaine seeking
following a cocaine prime. These findings are similar to an earlier
report that administration of daily N-acetylcysteine after heroin selfadministration but before extinction training resulted in blunted heroin
seeking during extinction and reinstatement testing (Zhou and Kalivas,
2007). Interestingly, acute disruption of system xc- following infusion
of the cystine-glutamate exchange inhibitor CPG into the nucleus
accumbens during the test for cocaine-primed reinstatement restored
cocaine seeking to the level observed in cocaine control rats that had
not received N-acetylcysteine prior to daily sessions of cocaine selfadministration. Collectively these data support the hypothesis that
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reduced system xc- activity promotes the capacity of a cocaine prime
to elicit cocaine seeking.
Additional work is needed to understand how N-acetylcysteine is
preventing plasticity involving system xc-. First, N-acetylcysteine may
maintain normal levels of cystine-glutamate exchange, which then
prevents cocaine-induced synaptic glutamate release by providing
normal tone on group II mGluRs. Thus, CPG may have restored
reinstatement by transiently lowering basal glutamate levels and
reducing tone on group II mGluRs resulting in an enhanced glutamate
response following a cocaine challenge. Alternatively, repeated Nacetylcysteine may have decreased the magnitude of cocaine
reinstatement by reducing cocaine intake. In support, earlier studies
have revealed a correlation between cocaine intake and magnitude of
cocaine-primed reinstatement (Sutton et al., 2000; Baker et al.,
2001). However, N-acetylcysteine pretreatment prior to daily sessions
of cocaine self administration under short-access conditions in our
earlier report did not result in lower cocaine intake, but still resulted in
blunted cocaine-induced reinstatement (Madayag et al., 2007).
Likewise, this approach also reduced behavioral sensitization in the
absence of altered cocaine intake (Madayag et al., 2007).
Interestingly, repeated N-acetylcysteine administered after heroin selfadministration resulted in reduced extinction responding (Zhou and
Kalivas, 2007). Lastly, the effects of daily N-acetylcysteine
pretreatment were reversed by producing an acute disruption of
cystine-glutamate exchange in the present study.

Conclusion
These data reveal that acute administration of N-acetylcysteine
targets system xc- to block cocaine primed reinstatement in rats
withdrawn from extended-access cocaine self-administration. Further,
reduced cystine-glutamate exchange appears to be necessary for
cocaine primed reinstatement. Collectively, these data provide further
support for cysteine prodrugs, including N-acetylcysteine, as potential
treatments for cocaine addiction by demonstrating efficacy after acute
and repeated administration. Further, it establishes system xc- as a
novel mechanism that likely contributes to plasticity rendering
corticostriatal pathways overactive. This is of particular interest
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because it is consistent with the concept that a mechanism releasing
nonvesicular glutamate from glial cells into an extrasynaptic
compartment contributes to pathological glutamate signaling.
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